Promedica International (PMI) has formed a strategic partnership with Dr. Agarwal’s Eye Hospitals (AEH) to conduct clinical trials in India.
The announcement was made at OCTANe’s Ophthalmology Technology Summit (OTS) held at the centre for Ophthalmology in Orange County, US.
Under the collaboration, which will allow for expansion of ophthalmology clinical research services, both the companies will jointly enrol and manage clinical studies in wide patient population.
PMI and AEH will also ensure that the studies conform with global and FDA qualification standards and regulations.
PMI president and CEO Shannon Stoddard said: “For PMI, this partnership will initially augment our resources for enrollment and management of FDA clinical trials. At the same time, AEH gains the opportunity to significantly improve their quality and volume of clinical research with timely execution of studies.
“Over the longer term, we believe this collaboration will enable both parties to build a global organization for conducting ophthalmic studies, and foster the development of proprietary models for multiple disease states.”
PMI is a US-based professional contract research organisation engaged in the design of studies that meet Good Clinical Practice quality standards.
Besides its expertise in clinical research, it offers project management, study management and monitoring, data management, statistical services, clinical quality assurance, medical writing and global regulatory support services.
AEH executive director and clinical services chief Dr Ashvin Agarwal said: “Dr. Agarwal’s Eye Hospitals welcomes the opportunity to work with PMI because of their success and the brand they have built performing their clinical study services on a global level.”
AEH is an international ophthalmic healthcare system, with clinical expertise and facility access in India.